Treatment of Anaemia in Haemodialysis Patients with Erythropoietin: Long-Term Effects on Exercise Capacity

1993 ◽  
Vol 84 (4) ◽  
pp. 441-447 ◽  
Author(s):  
Peter Báaráany ◽  
Ulla Freyschuss ◽  
Erna Pettersson ◽  
Jonas Bergström

1. The effects of correcting anaemia on exercise capacity were evaluated in 21 haemodialysis patients (aged 39 ± 12 years) before starting treatment with recombinant human erythropoietin (Hb concentration, 73 ± 10 g/l; total Hb, 59 ± 12% of expected), after correction of the anaemia to a Hb concentration of 108 ± 7 g/l and a total Hb 82 ± 10% of expected, and in 13 of the patients after 12 months on maintenance recombinant human erythropoietin treatment (Hb concentration 104 ± 14 g/l, total Hb 79 ± 17% of expected). Fifteen healthy subjects (aged 41 ± 9 years), who took no regular exercise, constituted the control group. Maximal exercise capacity was determined on a bicycle ergometer. Oxygen uptake, respiratory quotient, blood lactate concentration, heart rate and blood pressure were measured at rest and at maximal workload. 2. After 6 ± 3 months on recombinant human erythropoietin, maximal exercise capacity increased from 108 ± 27 W to 130 ± 36 W (P < 0.001) and the maximal oxygen uptake increased from 1.24 ± 0.39 litres/min to 1.50 ± 0.45 litres/min (P < 0.001). No significant changes in respiratory quotient (1.16 ± 0.13 versus 1.18 ± 0.13) and blood lactate concentration (4.0 ± 1.8 versus 3.6 ± 1.1 mmol/l) at maximal workload were observed, but the blood lactate concentration in the patients was significantly lower than that in the control subjects (6.7 ± 2.3 mmol/l, P < 0.01). After the correction of anaemia, the aerobic power was still 38% lower in the patients than in the control subjects and 17% lower than the reference values. 3. After 12 months on maintenance recombinant human erythropoietin treatment (17 ± 3 months from the start of the study), no further significant changes were observed in maximal exercise capacity (before start, 112 ± 31 W, 6 ± 3 months, 134 ± 42 W, 17 ± 3 months, 134 ± 50 W), maximal oxygen uptake (before start, 1.33 ± 0.45 litres/min; 6 ± 3 months, 1.59 ± 0.54 litres/min; 17 ± 3 months, 1.75 ± 0.78 litres/min) or blood lactate concentration (before start, 4.4 ± 1.9 mmol/l; 6 ± 3 months, 4.0 ± 1.0 mmol/l; 17 ± 3 months, 4.7 ± 2.0 mmol/l). 4. Thus, in haemodialysis patients the improvement in maximal aerobic power after the correction of anaemia persists without marked changes during long-term treatment with recombinant human erythropoietin. We did not observe any effects on exercise capacity that could be attributed to a spontaneous increase in physical activity after treatment of anaemia.

1981 ◽  
Vol 51 (4) ◽  
pp. 840-844 ◽  
Author(s):  
B. A. Stamford ◽  
A. Weltman ◽  
R. Moffatt ◽  
S. Sady

The purpose of this study was to determine the effects of resting and exercise recovery above [70% of maximum O2 uptake (VO2 max)] and below [40% of VO2 max] anaerobic threshold (AT) on blood lactate disappearance following maximal exercise. Blood lactate concentrations at rest (0.9 mM) and during exercise at 40% (1.3 mM) and 70% (3.5 mM) of VO2 max without preceding maximal exercise were determined on separate occasions and represented base lines for each condition. The rate of blood lactate disappearance from peak values was ascertained from single-component exponential curves fit for each individual subject for each condition using both the determined and resting base lines. When determined base lines were utilized, there were no significant differences in curve parameters between the 40 and 70% of VO2 max recoveries, and both were significantly different from the resting recovery. When a resting base line (0.9 mM) was utilized for all conditions, 40% of VO2 max demonstrated a significantly faster half time than either 70% of VO2 max or resting recovery. No differences were found between 70% of VO2 max and resting recovery. It was concluded that interpretation of the effectiveness of exercise recovery above and below AT with respect to blood lactate disappearance is influenced by the base-line blood lactate concentration utilized in the calculation of exponential half times.


2016 ◽  
Vol 37 (5) ◽  
pp. 536-543 ◽  
Author(s):  
Rosangela Akemi Hoshi ◽  
Luiz Carlos Marques Vanderlei ◽  
Moacir Fernandes de Godoy ◽  
Fábio do Nascimento Bastos ◽  
Jayme Netto ◽  
...  

2016 ◽  
Vol 41 (11) ◽  
pp. 1197-1203 ◽  
Author(s):  
Felipe Mattioni Maturana ◽  
Daniel A. Keir ◽  
Kaitlin M. McLay ◽  
Juan M. Murias

Critical power (CP) conceptually represents the highest power output (PO) at physiological steady-state. In cycling exercise, CP is traditionally derived from the hyperbolic relationship of ∼5 time-to-exhaustion trials (TTE) (CPHYP). Recently, a 3-min all-out test (CP3MIN) has been proposed for estimation of CP as well the maximal lactate steady-state (MLSS). The aim of this study was to compare the POs derived from CPHYP, CP3MIN, and MLSS, and the oxygen uptake and blood lactate concentrations at MLSS. Thirteen healthy young subjects (age, 26 ± 3years; mass, 69.0 ± 9.2 kg; height, 174 ± 10 cm; maximal oxygen uptake, 60.4 ± 5.9 mL·kg−1·min−1) were tested. CPHYP was estimated from 5 TTE. CP3MIN was calculated as the mean PO during the last 30 s of a 3-min all-out test. MLSS was the highest PO during a 30-min ride where the variation in blood lactate concentration was ≤ 1.0 mmol·L−1 during the last 20 min. PO at MLSS (233 ± 41 W; coefficient of variation (CoV), 18%) was lower than CPHYP (253 ± 44 W; CoV, 17%) and CP3MIN (250 ± 51 W; CoV, 20%) (p < 0.05). Limits of agreement (LOA) from Bland–Altman plots between CPHYP and CP3MIN (–39 to 31 W), and CP3MIN and MLSS (–29 to 62 W) were wide, whereas CPHYP and MLSS presented the narrowest LOA (–7 to 48 W). MLSS yielded not only the maximum PO of stable blood lactate concentration, but also stable oxygen uptake. In conclusion, POs associated to CPHYP and CP3MIN were larger than those observed during MLSS rides. Although CPHYP and CP3MIN were not different, the wide LOA between these 2 tests and the discrepancy with PO at MLSS questions the ability of CP measures to determine the maximal physiological steady-state.


2018 ◽  
Vol 25 (16) ◽  
pp. 1744-1751 ◽  
Author(s):  
Valentina Mantegazza ◽  
Mauro Contini ◽  
Maurizia Botti ◽  
Ada Ferri ◽  
Francesca Dotti ◽  
...  

Background Far-infrared-emitting garments have several biological properties including the capability to increase blood perfusion in irradiated tissues. Design The aim of the study was to evaluate whether far-infrared radiation increases exercise capacity and delays anaerobic metabolism in healthy subjects. Methods With a double-blind, crossover protocol, a maximal cardiopulmonary exercise test was performed in 20 volunteers, wearing far-infrared or common sport clothes, identical in texture and colour. Results Comparing far-infrared with placebo garments, higher oxygen uptake at peak of exercise and longer endurance time were observed (peak oxygen uptake 38.0 ± 8.9 vs. 36.2 ± 8.5 ml/kg/min, endurance time 592 ± 85 vs. 570 ± 71 seconds; P < 0.01); the anaerobic threshold was significantly delayed (anaerobic threshold time 461 ± 93 vs. 417 ± 103 seconds) and anaerobic threshold oxygen uptake and anaerobic threshold oxygen pulse were significantly higher (25.3 ± 6.4 vs. 20.9 ± 5.4 ml/kg/min and 13.3 ± 3.8 vs. 12.4 ± 3.3 ml/beat, respectively). In 10 subjects the blood lactate concentration was measured every 2 minutes during exercise and at peak; lower values were observed with far-infrared fabrics compared to placebo from the eighth minute of exercise, reaching a significant difference at 10 minutes (3.6 ± 0.83 vs. 4.4 ± 0.96 mmol/l; P = 0.02). Conclusions In healthy subjects, exercising with a far-infrared outfit is associated with an improvement in exercise performance and a delay in anaerobic metabolism. In consideration of the acknowledged non-thermic properties of functionalised clothes, these effects could be mediated by an increase in oxygen peripheral delivery secondary to muscular vasodilation. These data suggest the need for testing far-infrared-emitting garments in patients with exercise limitation or in chronic cardiovascular and respiratory patients engaged in rehabilitation programmes.


Sign in / Sign up

Export Citation Format

Share Document